International Nuclear Energy Research Initiative P

Safe and effective implementation of new closed n

International Nuclear Energy Research Initiative P

Safe and effective implementation of new closed n

Microstructural Changes In Thermally Cycled U-Pu-Zr-Am-Np Metallic Transmutation Fuel With 1.5% Lanthanides

The United States Department of Energy (DOE) Global Nuclear Energy Partnership (GNEP) is developing metallic actinide-zirconium alloy fuels for the transmutation of minor actinides as part of a closed fuel cycle. The molten salt electrochemical process to be used for fuel recycle has the potential to carry over up to 2% fission product lanthanide content into the fuel fabrication process. Within the scope of the fuel irradiation testing program at Idaho National Laboratory (INL), candidate metal alloy transmutation fuels containing quantities of lanthanide elements have been fabricated, characterized, and delivered to the Advanced Test Reactor for irradiation testing

An Electromotive Force Measurement System for Alloy Fuels

The development of advanced nuclear fuels requires a better understanding of the transmutation and micro-structural evolution of the materials. Alloy fuels have the advantage of high thermal conductivity and improved characteristics in fuel-cladding chemical reaction. However, information on thermodynamic and thermophysical properties is limited. The objective of this project is to design and build an experimental system to measure the thermodynamic properties of solid materials from which the understanding of their phase change can be determined. The apparatus was used to measure the electromotive force (EMF) of several materials in order to calibrate and test the system. The EMF of chromel was measured from 100°C to 800°C and compared with theoretical values. Additionally, the EMF measurement of Ni-Fe alloy was performed and compared with the Ni-Fe phase diagram. The prototype system is to be modified eventually and used in a radioactive hot-cell in the future

Hepatitis C reinfection following treatment induced viral clearance among people who have injected drugs

Background: Although people who inject drugs (PWID) are an important group to receive Hepatitis C Virus (HCV) antiviral therapy, initiation onto treatment remains low. Concerns over reinfection may make clinicians reluctant to treat this group. We examined the risk of HCV reinfection among a cohort of PWID (encompassing all those reporting a history of injecting drug use) from Scotland who achieved a sustained virological response (SVR). Methods: Clinical and laboratory data were used to monitor RNA testing among PWID who attained SVR following therapy between 2000 and 2009. Data were linked to morbidity and mortality records. Follow-up began one year after completion of therapy, ending on 31st December, 2012. Frequency of RNA testing during follow-up was calculated and the incidence of HCV reinfection estimated. Cox proportional hazards regression was used to examine factors associated with HCV reinfection. Results: Among 448 PWID with a SVR, 277 (61.8%) were tested during follow-up, median 4.5 years; 191 (69%) received one RNA test and 86 (31%) received at least two RNA tests. There were seven reinfections over 410 person years generating a reinfection rate of 1.7/100 py (95% CI 0.7–3.5). For PWID who have been hospitalised for an opiate or injection related cause post SVR (11%), the risk of HCV reinfection was greater [AHR = 12.9, 95% CI 2.2–76.0, p = 0.002] and the reinfection rate was 5.7/100 py (95% CI 1.8–13.3). Conclusion: PWID who have been tested, following SVR, for HCV in Scotland appear to be at a low risk of reinfection. Follow-up and monitoring of this population are warranted as treatment is offered more widely

The KIC 8462852 light curve from 2015.75 to 2018.18 shows a variable secular decline

The star KIC 8462852 (Boyajian's Star) displays both fast dips of up to 20% on time scales of days, plus long-term secular fading by up to 19% on time scales from a year to a century. We report on CCD photometry of KIC 8462852 from 2015.75 to 2018.18, with 19,176 images making for 1,866 nightly magnitudes in BVRI. Our light curves show a continuing secular decline (by 0.023±0.003 mags in the B-band) with three superposed dips with duration 120-180 days. This demonstrates that there is a continuum of dip durations from a day to a century, so that the secular fading is seen to be by the same physical mechanism as the short-duration Kepler dips. The BVRI light curves all have the same shape, with the slopes and amplitudes for VRI being systematically smaller than in the B-band by factors of 0.77±0.05, 0.50±0.05, and 0.31±0.05. We rule out any hypothesis involving occultation of the primary star by any star, planet, solid body, or optically thick cloud. But these ratios are the same as that expected for ordinary extinction by dust clouds. This chromatic extinction implies dust particle sizes going down to ˜0.1 micron, suggesting that this dust will be rapidly blown away by stellar radiation pressure, so the dust clouds must have formed within months. The modern infrared observations were taken at a time when there was at least 12.4%±1.3% dust coverage (as part of the secular dimming), and this is consistent with dimming originating in circumstellar dust

The Future of American Sentencing: A National Roundtable on Blakely

In the wake of the dramatic Supreme Court decision in Blakely v. Washington, Stanford Law School convened an assembly of the most eminent academic and professional sentencing experts in the country to jointly assess the meaning of the decision and its implications for federal and state sentencing reform. The event took place on October 8 and 9, just a few months after Blakely came down and the very week that the Supreme Court heard the arguments in United States v. Booker and United States v. Fanfan, the cases that will test Blakely\u27s application to the Federal Sentencing Guidelines. Thus the Roundtable offered these experts an intellectual breathing space at a crucial point in American criminal law. The event was built around six sessions, with shifting panels of participants doing brief presentations on the subject of the session, and with others then joining in the discussion. We are pleased that FSR is able to publish this version of the proceedings of the event-a condensed and edited transcript of the sessions

Differential modes of DNA binding by mismatch uracil DNA glycosylase from Escherichia coli: implications for abasic lesion processing and enzyme communication in the base excision repair pathway

Mismatch uracil DNA glycosylase (Mug) from Escherichia coli is an initiating enzyme in the base-excision repair pathway. As with other DNA glycosylases, the abasic product is potentially more harmful than the initial lesion. Since Mug is known to bind its product tightly, inhibiting enzyme turnover, understanding how Mug binds DNA is of significance when considering how Mug interacts with downstream enzymes in the base-excision repair pathway. We have demonstrated differential binding modes of Mug between its substrate and abasic DNA product using both band shift and fluorescence anisotropy assays. Mug binds its product cooperatively, and a stoichiometric analysis of DNA binding, catalytic activity and salt-dependence indicates that dimer formation is of functional significance in both catalytic activity and product binding. This is the first report of cooperativity in the uracil DNA glycosylase superfamily of enzymes, and forms the basis of product inhibition in Mug. It therefore provides a new perspective on abasic site protection and the findings are discussed in the context of downstream lesion processing and enzyme communication in the base excision repair pathway

Protective effect of human amniotic fluid stem cells in an immunodeficient mouse model of acute tubular necrosis.

Acute Tubular Necrosis (ATN) causes severe damage to the kidney epithelial tubular cells and is often associated with severe renal dysfunction. Stem-cell based therapies may provide alternative approaches to treating of ATN. We have previously shown that clonal c-kit(pos) stem cells, derived from human amniotic fluid (hAFSC) can be induced to a renal fate in an ex-vivo system. Herein, we show for the first time the successful therapeutic application of hAFSC in a mouse model with glycerol-induced rhabdomyolysis and ATN. When injected into the damaged kidney, luciferase-labeled hAFSC can be tracked using bioluminescence. Moreover, we show that hAFSC provide a protective effect, ameliorating ATN in the acute injury phase as reflected by decreased creatinine and BUN blood levels and by a decrease in the number of damaged tubules and apoptosis therein, as well as by promoting proliferation of tubular epithelial cells. We show significant immunomodulatory effects of hAFSC, over the course of ATN. We therefore speculate that AFSC could represent a novel source of stem cells that may function to modulate the kidney immune milieu in renal failure caused by ATN